EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stromal NNMT overexpression as an independent prognostic biomarker in lung adenocarcinoma and breast carcinoma

Yanzhong Wang iD, Yiping Wu, Shuyang Zheng, Xiaotian Yan, Xingtong Yu, Yuzhen Gao iD, Shuduo Xie, Zhinong Jiang iD, Rui An iD, Guoli Li, Jun Yang iD, Qingchao Tong iD und 2 weitere

Carcinogenesis · 2026

DOI: 10.1093/carcin/bgag020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Carcinogenesis, 2026. Verfasst von Yanzhong Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310016, China. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Breast Neoplasms, Nicotinamide N-Methyltransferase, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China, Key Research and Development Program of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the expression profile and prognostic significance of nicotinamide N-methyltransferase (NNMT) in pan-cancer stroma, with focused validation in lung adenocarcinoma (LUAD) and breast carcinoma (BC). Integrated analysis of Genotype-Tissue Expression and The Cancer Genome Atlas databases revealed tumor-specific NNMT mRNA upregulation in these malignancies. Subsequently, the relationship between NNMT mRNA expression levels and clinical parameters across multiple cancer types was examined, with particular emphasis on LUAD, BC, and CRC. Single-cell RNA sequencing data further revealed elevated NNMT expression specifically within stromal compartments, with fibroblasts exhibiting the highest NNMT expression levels among stromal cell populations. Protein-level validation using the Human Protein Atlas database, the National Cancer Institute's Proteomics Data Commons, and the quantitative immunohistochemistry of our independent clinical cohorts demonstrated elevated stromal NNMT protein expression, particularly in cancer-associated fibroblasts. Cox regression analysis and survival curve analysis established stromal NNMT expression as an independent prognostic factor for overall survival in LUAD and BC patients (P < .05). In conclusion, high stromal NNMT levels correlated with poor prognosis, establishing it as a promising biomarker for risk stratification in LUAD and BC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorBreast NeoplasmsNicotinamide N-MethyltransferaseLung NeoplasmsAdenocarcinoma of LungHumansFemalePrognosisGene Expression Regulation, NeoplasticStromal CellsMiddle AgedCancer-Associated FibroblastsMaleAged

Stichwörter der Autor:innen

NNMTbreast carcinomaindependent prognostic biomarkerlung adenocarcinomatumor stromal cell

Substanzen

Biomarkers, TumorNicotinamide N-MethyltransferaseNNMT protein, human

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310016, China.
  • Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province, Zhejiang Provincial Department of Science and Technology, Hangzhou, Zhejiang 310016, China.
  • Zhejiang Engineering Research Center for Intelligent Manufacturing of Clinical Diagnostic Equipment, Zhejiang Provincial Department of Science and Technology, Hangzhou, Zhejiang 310016, China.
  • School of Medicine, Shaoxing University, Shaoxing, Zhejiang 312000, China.
  • Department of Clinical Laboratory, Zhuji Second People's Hospital, Zhuji, Zhejiang 311811, China.
  • Department of Surgical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310016, P.R. China.

ORCID-Profile: Yanzhong Wang, Yuzhen Gao, Zhinong Jiang, Rui An, Jun Yang, Qingchao Tong, Xinyou Xie, Jun Zhang

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National Natural Science Foundation of China
  • Key Research and Development Program of Zhejiang Province
  • Natural Science Foundation of Zhejiang Province
  • Health Bureau Foundation of Zhejiang Province
  • Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province

Zitieren

APA

Wang, Y., Wu, Y., Zheng, S., Yan, X., Yu, X., Gao, Y., Xie, S., Jiang, Z., An, R., Li, G., Yang, J., Tong, Q., Xie, X., & Zhang, J. (2026). Stromal NNMT overexpression as an independent prognostic biomarker in lung adenocarcinoma and breast carcinoma. Carcinogenesis. https://doi.org/10.1093/carcin/bgag020

Vancouver

Wang Y, Wu Y, Zheng S, Yan X, Yu X, Gao Y, et al. Stromal NNMT overexpression as an independent prognostic biomarker in lung adenocarcinoma and breast carcinoma. Carcinogenesis. 2026. doi:10.1093/carcin/bgag020

BibTeX
@article{Wang2026,
  author = {Wang, Yanzhong and Wu, Yiping and Zheng, Shuyang and Yan, Xiaotian and Yu, Xingtong and Gao, Yuzhen and Xie, Shuduo and Jiang, Zhinong and An, Rui and Li, Guoli and Yang, Jun and Tong, Qingchao and Xie, Xinyou and Zhang, Jun},
  title = {Stromal NNMT overexpression as an independent prognostic biomarker in lung adenocarcinoma and breast carcinoma},
  journal = {Carcinogenesis},
  year = {2026},
  doi = {10.1093/carcin/bgag020}
}
Kostenlos starten →